{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T05:10:22Z","timestamp":1680325822885},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0446","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T22:09:50Z","timestamp":1668463790000},"page":"259-265","source":"Crossref","is-referenced-by-count":1,"title":["Successful diagnosis and treatment of pheochromocytoma during severe coronavirus disease 2019 (COVID-19): a case report"],"prefix":"10.1507","volume":"70","author":[{"given":"Yasutaka","family":"Tsujimoto","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Nishikage","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Kanie","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Kanzawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Gandhi TK, Singh H (2020) Reducing the risk of diagnostic error in the COVID-19 era. J Hosp Med 15: 363\u2013366.","DOI":"10.12788\/3461"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Stelfox HT, Bates DW, Redelmeier DA (2003) Safety of patients isolated for infection control. JAMA 290: 1899\u20131905.","DOI":"10.1001\/jama.290.14.1899"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bancos I, Prete A (2021) Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab 106: 3331\u20133353.","DOI":"10.1210\/clinem\/dgab512"},{"key":"4","unstructured":"4 Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58: 802\u2013804."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, et al. (2013) Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab 98: 581\u2013591.","DOI":"10.1210\/jc.2012-3020"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Whitelaw BC, Prague JK, Mustafa OG, Schulte KM, Hopkins PA, et al. (2014) Phaeochromocytoma crisis. Clin Endocrinol (Oxf) 80: 13\u201322.","DOI":"10.1111\/cen.12324"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Guerrero MA, Schreinemakers JMJ, Vriens MR, Suh I, Hwang J, et al. (2009) Clinical spectrum of pheochromocytoma. J Am Coll Surg 209: 727\u2013732.","DOI":"10.1016\/j.jamcollsurg.2009.09.022"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Lenders JWM, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366: 665\u2013675.","DOI":"10.1016\/S0140-6736(05)67139-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, et al. (2007) Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf 30: 1031\u20131062.","DOI":"10.2165\/00002018-200730110-00004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, et al. (2008) Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol 158: 423\u2013429.","DOI":"10.1530\/EJE-07-0778"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Rebollo-Rom\u00e1n A, Alhambra-Exp\u00f3sito MR, Herrera-Mart\u00ednez Y, Leiva-Cepas F, Alzas C, et al. (2021) Catecholaminergic crisis after a bleeding complication of COVID-19 Infection: a case report. Front Endocrinol (Lausanne) 12: 693004.","DOI":"10.3389\/fendo.2021.693004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Naghshineh H, Hasanpour A, Ziaei N, Sadeghi M, Meftah N (2022) Pheochromocytoma triggered by coronavirus disease 2019: a case report. J Med Case Rep 16: 233.","DOI":"10.1186\/s13256-022-03378-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, et al. (2020) Hematological findings and complications of COVID-19. Am J Hematol 95: 834\u2013847.","DOI":"10.1002\/ajh.25829"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Oberbeck R (2006) Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem 13: 1979\u20131989.","DOI":"10.2174\/092986706777584997"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Wang JS, Cheng LJ (1999) Effect of strenuous, acute exercise on alpha2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 19: 1559\u20131565.","DOI":"10.1161\/01.ATV.19.6.1559"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ziegler MG, Bao X, Kennedy BP, Joyner A, Enns R (2002) Location, development, control, and function of extraadrenal phenylethanolamine N-methyltransferase. Ann N Y Acad Sci 971: 76\u201382.","DOI":"10.1111\/j.1749-6632.2002.tb04437.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Barrett C, van Uum SHM, Lenders JWM (2015) Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review. Clin Endocrinol (Oxf) 83: 622\u2013628.","DOI":"10.1111\/cen.12813"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, et al. (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45: 469\u2013478.","DOI":"10.1007\/s12020-013-0007-y"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, et al. (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371: 1921\u20131926.","DOI":"10.1016\/S0140-6736(08)60834-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Mao JJ, Baker JE, Rainey WE, Young WF Jr, Bancos I (2021) Concomitant pheochromocytoma and primary aldosteronism: a case series and literature review. J Endocr Soc 5: bvab107.","DOI":"10.1210\/jendso\/bvab107"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yamada T, Fukuoka H, Hosokawa Y, Odake Y, Yoshida K, et al. (2020) Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports. BMC Endocr Disord 20: 140.","DOI":"10.1186\/s12902-020-00620-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sakamoto N, Tojo K, Saito T, Fujimoto K, Isaka T, et al. (2009) Coexistence of aldosterone-producing adrenocortical adenoma and pheochromocytoma in an ipsilateral adrenal gland. Endocr J 56: 213\u2013219.","DOI":"10.1507\/endocrj.K08E-196"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K (2020) Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol 8: 978\u2013986.","DOI":"10.1016\/S2213-8587(20)30342-9"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, et al. (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033\u20131034.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Chen G, Wu D, Guo W, Cao Y, Huang D, et al. (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130: 2620\u20132629.","DOI":"10.1172\/JCI137244"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Zhou F, Yu T, Du R, Fan G, Liu Y, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054\u20131062.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med 353: 1711\u20131723.","DOI":"10.1056\/NEJMra050541"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, et al. (2020) Preventing cytokine storm syndrome in COVID-19 using \u03b1-1 adrenergic receptor antagonists. J Clin Invest 130: 3345\u20133347.","DOI":"10.1172\/JCI139642"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Staedtke V, Bai RY, Kim K, Darvas M, Davila ML, et al. (2018) Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 564: 273\u2013277.","DOI":"10.1038\/s41586-018-0774-y"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/3\/70_EJ22-0446\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T04:55:38Z","timestamp":1680324938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/3\/70_EJ22-0446\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0446","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0446"}}